Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

Share Price is delayed by 15 minutes
Get Live Data
6,870.00    115.00 (1.70%)
Bid:
6,855.00
Ask:
6,860.00
Spread: 5.00 (0.073%)
Market Cap: £30.42b
CCEP Live PriceLast checked at - London Stock Exchange

Intraday Coca-cola Euro. Share Chart

Transaction in Own Shares

3 Mar 2025 07:00

RNS Number : 9826Y
Coca-Cola Europacific Partners plc
03 March 2025
 

Coca-Cola Europacific Partners plc (the "Company")Transactions in Own Shares

 

The Company confirms that on 28 February 2025 it purchased a total of: (i) 38,088 ordinary shares of EUR 0.01 ("ordinary shares") on the US Trading Venues[1] and (ii) 12,756 ordinary shares on the London Trading Venues[2]; in both cases, from Goldman Sachs & Co. LLC, Goldman Sachs International or one of their affiliates, as detailed below.

The repurchased ordinary shares will be cancelled.

 

US Trading Venues

London Stock Exchange

CBOE Europe Limited

(CXE)

 

CBOE Europe Limited

(BXE)

Aquis

Date of purchase

 

28 February 2025

 

28 February 2025

 

28 February 2025

 

28 February 2025

 

28 February 2025

Aggregate number of ordinary shares purchased

38,088

7,654

1,275

3,827

0

Highest price paid (per ordinary share)

USD 87.1400

GBP 69.0000

GBP 68.8000

GBP 69.0000

GBP 0

Lowest price paid (per ordinary share)

USD 85.7200

GBP 68.2000

GBP 68.4000

GBP 68.2000

GBP 0

Volume weighted average price paid (per ordinary share)

USD 86.1433

GBP 68.4792

GBP 68.5738

GBP 68.5719

GBP 0

 

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 billion of ordinary shares (in aggregate).

This announcement does not constitute, or form part of, an offer or solicitation of an offer for securities in any jurisdiction.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, are set out in the Schedule to this announcement available through the link below:

http://www.rns-pdf.londonstockexchange.com/rns/9826Y_1-2025-3-2.pdf

 

CONTACTS

Company Secretariat

Clare Wardle

clare.wardle@ccep.com

Investor Relations

Sarah Willett

sarah.willett@ccep.com

Media Relations

Shanna Wendt

mediaenquiries@ccep.com

 

ABOUT CCEP

Coca-Cola Europacific Partners is one of the world's leading consumer goods companies. We make, move and sell some of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.

The Company is currently listed on Euronext Amsterdam, NASDAQ (and a constituent of the Nasdaq 100), London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

For more information about CCEP, please visit www.cocacolaep.com and follow CCEP on LinkedIn

 

 

 

 

 


[1] The "US Trading Venues" comprise Nasdaq and other applicable US trading venues.

[2] The "London Trading Venues" comprise the London Stock Exchange, CBOE Europe Limited (BXE), CBOE Europe Limited (CXE) and Aquis. Goldman Sachs acquired CREST Depositary Interests on the London Trading Venues, which will be cancelled together with the underlying shares they represent.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUUVARVNUORAR
Date   Source Headline
27th May 202112:00 pmRNSResult of AGM
20th May 20211:00 pmRNSDirector/PDMR Shareholding
13th May 20212:45 pmRNSLetter to Shareholders
11th May 202112:30 pmRNSInvestor event following acquisition of Amatil
11th May 20217:00 amRNSQ1 2021 Trading Update
10th May 202111:00 amRNSChange of Name
4th May 20212:00 pmRNSTotal Voting Rights
27th Apr 20214:36 pmRNSPrice Monitoring Extension
21st Apr 20215:30 pmRNSDirector/PDMR Shareholding
21st Apr 20217:00 amRNSAnnounces new company name and investor event
20th Apr 20218:10 amRNSCCEP Unaudited Pro Forma Combined Financial Info
15th Apr 20211:30 pmRNSNotice of AGM
15th Apr 20218:04 amRNSCCEP confirms regulatory approval from NZ OIO
13th Apr 202111:00 amRNSDirectorate Change
1st Apr 20213:00 pmRNSTotal Voting Rights
31st Mar 20213:22 pmRNSUpdate re Coca-Cola Amatil Financing
24th Mar 202112:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSDirector/PDMR Shareholding
17th Mar 20216:00 pmRNSBlock listing Interim Review
12th Mar 20215:31 pmRNSAnnual Financial Report
12th Mar 20217:00 amRNSScheme booklet registered by Coca-Cola Amatil
1st Mar 20214:00 pmRNSTotal Voting Rights
24th Feb 202111:00 amRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSBest and final offer to acquire Coca-Cola Amatil
11th Feb 20217:00 amRNSPreliminary Unaudited Results Q4 & FY 2020
1st Feb 20213:00 pmRNSTotal Voting Rights
1st Feb 20217:00 amRNSCCEP receives FIRB approval to acquire CCL
22nd Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 202111:00 amRNSDirector/PDMR Shareholding
4th Jan 20212:30 pmRNSTotal Voting Rights
4th Jan 20211:30 pmRNSCoca-Cola European Partners plc Home Member State
23rd Dec 20201:00 pmRNSDirector/PDMR Shareholding
14th Dec 20204:30 pmRNSDirector/PDMR Shareholding
11th Dec 202011:30 amRNSDirector/PDMR Shareholding
1st Dec 20205:15 pmRNSTotal Voting Rights
1st Dec 20205:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20201:45 pmRNSDirector/PDMR Shareholding
11th Nov 20205:30 pmRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSUpdate re Coca-Cola Amatil acquisition
2nd Nov 20204:00 pmRNSTotal Voting Rights
29th Oct 20205:45 pmRNSDirector/PDMR Shareholding
26th Oct 20207:05 amRNSQ3 Trading Update & Interim Dividend Declaration
26th Oct 20207:00 amRNSProposed acquisition of Coca-Cola Amatil
22nd Oct 20201:00 pmRNSDirectorate Change
20th Oct 20203:00 pmRNSDirector/PDMR Shareholding
6th Oct 20205:00 pmRNSDirector/PDMR Shareholding
1st Oct 20205:10 pmRNSTotal Voting Rights
23rd Sep 202011:00 amRNSDirector/PDMR Shareholding
17th Sep 20202:00 pmRNSBlock listing Interim Review
14th Sep 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.